Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
Relay Therapeutics (NASDAQ:RLAY), a clinical-stage precision medicine company focused on developing therapies for cancer and genetic diseases, has announced its participation in two major investor conferences in September 2025.
Management will engage in fireside chats at the 2025 Wells Fargo Healthcare Conference on September 4 at 2:15 p.m. ET and the Morgan Stanley 23rd Annual Global Conference on September 10 at 11:30 a.m. ET. Both presentations will be available via webcast on the company's investor relations website, with replays accessible for 30 days after the events.
Relay Therapeutics (NASDAQ:RLAY), azienda clinica di medicina di precisione focalizzata sullo sviluppo di terapie per il cancro e le malattie genetiche, ha annunciato la propria partecipazione a due importanti conferenze per investitori a settembre 2025.
La direzione prender脿 parte a fireside chat al 2025 Wells Fargo Healthcare Conference il 4 settembre alle 14:15 ET e al Morgan Stanley 23rd Annual Global Conference il 10 settembre alle 11:30 ET. Entrambe le presentazioni saranno trasmesse in webcast sul sito investor relations della societ脿, con le repliche disponibili per 30 giorni dopo gli eventi.
Relay Therapeutics (NASDAQ:RLAY), una compa帽铆a cl铆nica de medicina de precisi贸n centrada en desarrollar terapias para el c谩ncer y enfermedades gen茅ticas, ha anunciado su participaci贸n en dos importantes conferencias para inversores en septiembre de 2025.
La direcci贸n participar谩 en charlas tipo fireside en la 2025 Wells Fargo Healthcare Conference el 4 de septiembre a las 2:15 p.m. ET y en la Morgan Stanley 23rd Annual Global Conference el 10 de septiembre a las 11:30 a.m. ET. Ambas presentaciones estar谩n disponibles en webcast en la web de relaciones con inversores de la compa帽铆a, con las repeticiones accesibles durante 30 d铆as tras los eventos.
Relay Therapeutics (NASDAQ:RLAY)電� 鞎� 氚� 鞙犾爠 歆堩櫂 旃橂鞝� 臧滊皽鞐� 欤茧牓頃橂姅 鞛勳儊 雼硠 鞝曤皜 鞚橅暀 旮办梾鞙茧, 2025雲� 9鞗旍棎 鞐措Μ電� 霊� 臧滌潣 欤检殧 韴瀽鞛� 旎嵓霟办姢鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟.
瓴届榿歆勋潃 2025 Wells Fargo Healthcare Conference鞐愳劀 9鞗� 4鞚� 鞓ろ泟 2鞁� 15攵�(ET)鞐�, Morgan Stanley 23rd Annual Global Conference鞐愳劀電� 9鞗� 10鞚� 鞓れ爠 11鞁� 30攵�(ET)鞐� 韺岇澊鞏挫偓鞚措摐 毂楈棎 彀胳棳頃╇媹雼�. 霊� 氚滍憸 氇憪 須岇偓 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 鞗轨簮鞀ろ姼搿� 鞁滌箔頃� 靾� 鞛堨溂氅�, 鞚措菠韸� 膦呺 頉� 30鞚缄皠 雼れ嫓氤搓赴 靹滊箘鞀るゼ 鞝滉车頃╇媹雼�.
Relay Therapeutics (NASDAQ:RLAY), une soci茅t茅 en phase clinique sp茅cialis茅e en m茅decine de pr茅cision et d茅di茅e au d茅veloppement de traitements contre le cancer et les maladies g茅n茅tiques, a annonc茅 sa participation 脿 deux grandes conf茅rences investisseurs en septembre 2025.
La direction participera 脿 des 芦 fireside chats 禄 lors du 2025 Wells Fargo Healthcare Conference le 4 septembre 脿 14h15 ET et du Morgan Stanley 23rd Annual Global Conference le 10 septembre 脿 11h30 ET. Les deux pr茅sentations seront diffus茅es en webcast sur le site relations investisseurs de la soci茅t茅, avec des rediffusions accessibles pendant 30 jours apr猫s les 茅v茅nements.
Relay Therapeutics (NASDAQ:RLAY), ein klinisch t盲tiges Unternehmen f眉r Pr盲zisionsmedizin, das sich auf die Entwicklung von Therapien gegen Krebs und genetische Erkrankungen konzentriert, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im September 2025 bekanntgegeben.
Das Management wird an Fireside-Chats teilnehmen: beim 2025 Wells Fargo Healthcare Conference am 4. September um 14:15 Uhr ET und beim Morgan Stanley 23rd Annual Global Conference am 10. September um 11:30 Uhr ET. Beide Pr盲sentationen werden per Webcast auf der Investor-Relations-Website des Unternehmens verf眉gbar sein; Replays sind 30 Tage nach den Veranstaltungen abrufbar.
- None.
- None.
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in September:
- 2025 Wells Fargo Healthcare Conference on Thursday, September 4, 2025 at 2:15 p.m. ET
- Morgan Stanley 23rd Annual Global Conference on Wednesday, September 10, 2025 at 11:30 a.m. ET
The fireside chats will be webcast live and may be accessed through Relay Therapeutics鈥� website under Events in the News & Events section through the following link: . An archived replay of the webcast will be available for up to 30 days following the event.
About Relay Therapeutics
Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage, small molecule precision medicine company developing聽potentially life-changing therapies for聽patients living with cancer and genetic disease. Relay's Dynamo庐 platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The company鈥檚 lead clinical asset,聽RLY-2608, is the first pan-mutant selective PI3K伪 inhibitor to enter clinical development and聽is currently in a Phase 3 clinical trial (ReDiscover-2) in HR+/HER2- metastatic breast cancer. RLY-2608 is also being investigated in a group of genetic disease indications called PI3K伪-driven vascular malformations. Relay's聽pipeline also includes late-stage research programs for NRAS-driven solid tumors and Fabry disease. For more information, please visit聽听辞谤听.
Contact:
Pete Rahmer
Media:
Dan Budwick
1AB
973-271-6085
FAQ
When is Relay Therapeutics (RLAY) presenting at the Wells Fargo Healthcare Conference 2025?
When is RLAY's presentation at the Morgan Stanley Global Conference 2025?
How can investors access Relay Therapeutics' (RLAY) conference presentations?
What type of company is Relay Therapeutics (RLAY)?
